SCHEMBL6671364

SCHEMBL6671364

CC(C)Oc1ccc2[nH]cc(C(=O)O)c2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
PRKAG1 P54619 5/20 0.39
PRKAA1 Q13131 5/20 0.39
PRKAB1 Q9Y478 5/20 0.39
F7 P08709 1/20 0.38
F3 P13726 1/20 0.38
PRKAB2 O43741 3/20 0.38
PRKAA2 P54646 3/20 0.38
PRKAG3 Q9UGI9 3/20 0.38
PRKAG2 Q9UGJ0 3/20 0.38
JAK2 O60674 2/20 0.37
JAK1 P23458 2/20 0.37
JAK3 P52333 2/20 0.37
S1PR1 P21453 1/20 0.36
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PIM1 P11309 3/20 0.35
PIM2 Q9P1W9 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30267364 0.84 MTNR1A (0.53) ALDH1A1MTNR1AMTNR1BPRKAG1PRKAA1
SCHEMBL6667683 0.84 MTNR1A (0.53) ALDH1A1MTNR1AMTNR1BPRKAG1PRKAA1
SCHEMBL6728722 0.80 MAPT (0.44) ALDH1A1MTNR1AMTNR1BPRKAG1PRKAA1
SCHEMBL6734102 0.77 PRKAG1 (0.46) ALDH1A1MTNR1AMTNR1BPRKAG1PRKAA1
SCHEMBL14655309 0.76 JAK3 (0.55) JAK2JAK1JAK3
SCHEMBL22050698 0.75 F7 (0.44) PRKAG1PRKAA1PRKAB1F7F3
SCHEMBL6722084 0.75 PIM1 (0.48) ALDH1A1MTNR1AMTNR1BPIM1PIM2
SCHEMBL6724677 0.75 HTR1F (0.42) MTNR1AMTNR1BPRKAG1PRKAA1PRKAB1
SCHEMBL5606528 0.74 MTNR1A (0.50) ALDH1A1MTNR1AMTNR1BPRKAG1PRKAA1
SCHEMBL6722059 0.74 ALDH1A1 (0.43) ALDH1A1MTNR1AMTNR1BPOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453831-A1 1H-PYRROLO(3,2-B)PYRIDINE-3-CARBOXYLIC ACID AMIDES Neurogen Corporation (US) 2004-09-08 EP claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US claimed
WO-2003044018-A1 1H-PYRROLO[3,2-B]PYRIDINE-3-CARBOXYLIC ACID AMIDES NEUROGEN CORPORATION (US) 2003-05-30 WO claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US disclosed